Edarbyclor Drug Interactions: 15 Major, 420 Moderate
Edarbyclor (Azilsartan Kamedoxomil And Chlorthalidone) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Edarbyclor. Always confirm against the full prescribing information.
100 interactions
Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Chlorthalidone.
Level 2 evidence
Aceclofenac
The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Aceclofenac.
Level 2 evidence
Aceclofenac
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Aceclofenac.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Acetylsalicylic acid.
Level 1 evidence
Acetylsalicylic acid
Acetylsalicylic acid may decrease the excretion rate of Chlorthalidone which could result in a higher serum level.
Level 1 evidence
Alfentanil
The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Alfentanil.
Level 2 evidence
Allopurinol
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Chlorthalidone.
Level 1 evidence
Alogliptin
The therapeutic efficacy of Alogliptin can be decreased when used in combination with Chlorthalidone.
Level 2 evidence
Alogliptin
The risk or severity of angioedema can be increased when Alogliptin is combined with Azilsartan medoxomil.
Level 2 evidence
Alteplase
The risk or severity of angioedema can be increased when Alteplase is combined with Azilsartan medoxomil.
Level 2 evidence
Amiloride
The risk or severity of hyperkalemia can be increased when Azilsartan medoxomil is combined with Amiloride.
Level 1 evidence
Amobarbital
The risk or severity of hypotension and orthostatic hypotension can be increased when Amobarbital is combined with Chlorthalidone.
Level 2 evidence
Amobarbital
Amobarbital may increase the hypotensive activities of Azilsartan medoxomil.
Level 2 evidence
Enter your NPI to unlock 3 major interactions for Edarbyclor
Edarbyclor (Azilsartan Kamedoxomil And Chlorthalidone) has 1213 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Edarbyclor (Azilsartan Kamedoxomil And Chlorthalidone) has 15 major, 420 moderate, and 778 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Edarbyclor. Always confirm against the full prescribing information.